European Respiratory Journal最新文献

筛选
英文 中文
Pulmonary gas exchange in relation to exercise pulmonary hypertension in patients with heart failure with preserved ejection fraction. 射血分数保留型心力衰竭患者肺气体交换与运动性肺动脉高压的关系。
IF 16.6 1区 医学
European Respiratory Journal Pub Date : 2025-02-13 Print Date: 2025-02-01 DOI: 10.1183/13993003.00722-2024
Bryce N Balmain, Andrew R Tomlinson, Josh T Goh, James P MacNamara, Denis J Wakeham, Tiffany L Brazile, Michael G Leahy, Kevin C Lutz, Linda S Hynan, Benjamin D Levine, Satyam Sarma, Tony G Babb
{"title":"Pulmonary gas exchange in relation to exercise pulmonary hypertension in patients with heart failure with preserved ejection fraction.","authors":"Bryce N Balmain, Andrew R Tomlinson, Josh T Goh, James P MacNamara, Denis J Wakeham, Tiffany L Brazile, Michael G Leahy, Kevin C Lutz, Linda S Hynan, Benjamin D Levine, Satyam Sarma, Tony G Babb","doi":"10.1183/13993003.00722-2024","DOIUrl":"10.1183/13993003.00722-2024","url":null,"abstract":"<p><strong>Background: </strong>Exercise pulmonary hypertension, defined as a mean pulmonary arterial pressure (mPAP)/cardiac output (<i>Q̇c</i>) slope >3 WU during exercise, is common in patients with heart failure with preserved ejection fraction (HFpEF). However, the pulmonary gas exchange-related effects of an exaggerated exercise pulmonary hypertension (EePH) response are not well defined, especially in relation to dyspnoea on exertion and exercise intolerance.</p><p><strong>Methods: </strong>48 HFpEF patients underwent invasive (pulmonary and radial artery catheters) constant-load (20 W) and maximal incremental cycle testing. Haemodynamic measurements (mPAP and <i>Q̇c</i>), arterial blood and expired gases, and ratings of perceived breathlessness (Borg 0-10 scale) were obtained. The mPAP/<i>Q̇c</i> slope was calculated from rest to 20 W. Those with a mPAP/<i>Q̇c</i> slope ≥4.2 (median) were classified as HFpEF+EePH (n=24) and those with a mPAP/<i>Q̇c</i> slope <4.2 were classified as HFpEF (without EePH) (n=24). The alveolar-arterial oxygen tension difference, dead space to tidal volume ratio (Bohr equation) and the minute ventilation to carbon dioxide production slope (from rest to 20 W) were calculated.</p><p><strong>Results: </strong>Arterial oxygen tension was lower (p=0.03) and dead space to tidal volume ratio was higher (p=0.03) at peak exercise in HFpEF+EePH than in HFpEF. The alveolar-arterial oxygen tension difference was similar at peak exercise between groups (p=0.14); however, patients with HFpEF+EePH achieved the peak alveolar-arterial oxygen tension difference at a lower peak work rate (p<0.01). The minute ventilation to carbon dioxide production slope was higher in HFpEF+EePH than in HFpEF (p=0.01). Perceived breathlessness was ≥1 unit higher at 20 W and peak oxygen uptake was lower (p<0.01) in HFpEF+EePH than in HFpEF.</p><p><strong>Conclusions: </strong>These data suggest that EePH contributes to pulmonary gas exchange impairments during exercise by causing a ventilation/perfusion mismatch that provokes both ventilatory inefficiency and hypoxaemia, both of which seem to contribute to dyspnoea on exertion and exercise intolerance in patients with HFpEF.</p>","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":" ","pages":""},"PeriodicalIF":16.6,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142603762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Childhood interstitial lung disease survivors in adulthood: a European collaborative study. 成年期儿童间质性肺病幸存者:一项欧洲合作研究。
IF 16.6 1区 医学
European Respiratory Journal Pub Date : 2025-02-13 Print Date: 2025-02-01 DOI: 10.1183/13993003.00680-2024
Effrosyni D Manali, Matthias Griese, Nadia Nathan, Yurdagül Uzunhan, Raphael Borie, Katarzyna Michel, Nicolaus Schwerk, Justyna Fijolek, Elżbieta Radzikowska, Felix Chua, Rishi Pabary, Nesrin Mogulkoc, Cormac McCarthy, Maria Kallieri, Andriana I Papaioannou, Nural Kiper, Martina Koziar Vasakova, Ladislav Lacina, Maria Molina-Molina, Alba Torrent-Vernetta, Theofanis Tsiligiannis, Bulent Karadag, Maria Kokosi, Elisabetta A Renzoni, Coline H M van Moorsel, Ilaria Campo, Elisabeth Bendstrup, Thomas Skovhus Prior, Antje Prasse, Francesco Bonella, Vincent Cottin, Rémi Diesler, Antoine Froidure, Lykourgos Kolilekas, Lampros Fotis, Konstantinos Douros, Athanasios G Kaditis, Florence Jeny, Simon Chauveau, Hilario Nunes, Azrine Dahbia, Francesca Mariani, Joanne J van der Vis, Karlijn Groen, Ela Erdem Eralp, Yasemin Gokdemir, Derya Kocakaya, Sehnaz Olgun Yildizeli, Ebru Yalçın, Nagehan Emiralioğlu, Halime Nayir Buyuksahin, Helen O'Brien, Oguz Karcıoglu, Demet Can, Alper Ezircan, Gokcen Kartal Ozturk, Nesrin Ocal, Hasan Yuksel, Sedef Narin Tongal, Martina Safrankova, Katerina Kourtesi, Camille Louvrier, Caroline Kannengiesser, Aurelie Fabre, Marie Legendre, Bruno Crestani, Petr Pohunek, Andrew Bush, Spyros A Papiris
{"title":"Childhood interstitial lung disease survivors in adulthood: a European collaborative study.","authors":"Effrosyni D Manali, Matthias Griese, Nadia Nathan, Yurdagül Uzunhan, Raphael Borie, Katarzyna Michel, Nicolaus Schwerk, Justyna Fijolek, Elżbieta Radzikowska, Felix Chua, Rishi Pabary, Nesrin Mogulkoc, Cormac McCarthy, Maria Kallieri, Andriana I Papaioannou, Nural Kiper, Martina Koziar Vasakova, Ladislav Lacina, Maria Molina-Molina, Alba Torrent-Vernetta, Theofanis Tsiligiannis, Bulent Karadag, Maria Kokosi, Elisabetta A Renzoni, Coline H M van Moorsel, Ilaria Campo, Elisabeth Bendstrup, Thomas Skovhus Prior, Antje Prasse, Francesco Bonella, Vincent Cottin, Rémi Diesler, Antoine Froidure, Lykourgos Kolilekas, Lampros Fotis, Konstantinos Douros, Athanasios G Kaditis, Florence Jeny, Simon Chauveau, Hilario Nunes, Azrine Dahbia, Francesca Mariani, Joanne J van der Vis, Karlijn Groen, Ela Erdem Eralp, Yasemin Gokdemir, Derya Kocakaya, Sehnaz Olgun Yildizeli, Ebru Yalçın, Nagehan Emiralioğlu, Halime Nayir Buyuksahin, Helen O'Brien, Oguz Karcıoglu, Demet Can, Alper Ezircan, Gokcen Kartal Ozturk, Nesrin Ocal, Hasan Yuksel, Sedef Narin Tongal, Martina Safrankova, Katerina Kourtesi, Camille Louvrier, Caroline Kannengiesser, Aurelie Fabre, Marie Legendre, Bruno Crestani, Petr Pohunek, Andrew Bush, Spyros A Papiris","doi":"10.1183/13993003.00680-2024","DOIUrl":"10.1183/13993003.00680-2024","url":null,"abstract":"<p><strong>Background: </strong>Interstitial lung disease is rarer in children than adults, but, with increasing diagnostic awareness, more cases are being discovered. The prognosis of childhood interstitial lung disease is often poor, but increasing numbers are now surviving into adulthood.</p><p><strong>Aim: </strong>To characterise childhood interstitial lung disease survivors and identify their impact on adult interstitial lung disease centres.</p><p><strong>Methods: </strong>This was a European study (34 adult and childhood interstitial lung disease centres) reporting incident/prevalent cases of childhood interstitial lung disease survivors from January to July 2023. Epidemiological, clinical, physiological and genetic data were collected.</p><p><strong>Results: </strong>244 patients were identified with a median (interquartile range) age at diagnosis of 12.5 years (6-16 years) and age at study inclusion of 25 years (22-33 years), with 51% male, 86% nonsmokers and a median (interquartile range) % predicted forced vital capacity of 70% (47-89%) and diffusing capacity of the lungs for carbon monoxide of 48% (32-75%). 32% were prescribed long-term oxygen and 227 (93%) were followed up in adult centres whereas 17 (7%) never transitioned. The commonest diagnoses (82%) were childhood interstitial lung disease category B1 (sarcoidosis, hemosiderosis, connective tissue disorders, vasculitis) at 35%, A4 (surfactant-related) at 21%, B2 (bronchiolitis obliterans, hypersensitivity pneumonitis) at 14% and Bz (unclassified interstitial lung disease) at 13%. Bz patients had the worst functional status. 60% of all patients were still being prescribed corticosteroids. Re-specification of diagnosis and treatment were made after transition for 9.8% and 16% of patients, respectively. Not all childhood interstitial lung disease diagnoses were recognised in adult interstitial lung disease classifications.</p><p><strong>Conclusion: </strong>Childhood interstitial lung disease survivors are seen in most adult interstitial lung disease centres and only a minority continue follow-up in paediatric centres. Survivors have a significant loss of lung function. The heterogeneity of their aetiologies and therapeutic requirements has a real impact on adult interstitial lung disease centres. Re-specification of diagnosis and treatment may contribute to precision and personalisation of management.</p>","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":" ","pages":""},"PeriodicalIF":16.6,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142785027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heart or lungs? Why not both! 心脏还是肺?为什么不两者兼而有之!
IF 16.6 1区 医学
European Respiratory Journal Pub Date : 2025-02-13 Print Date: 2025-02-01 DOI: 10.1183/13993003.02308-2024
Vishal N Rao, Brian A Houston, Peter J Leary
{"title":"Heart or lungs? Why not both!","authors":"Vishal N Rao, Brian A Houston, Peter J Leary","doi":"10.1183/13993003.02308-2024","DOIUrl":"https://doi.org/10.1183/13993003.02308-2024","url":null,"abstract":"","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":"65 2","pages":""},"PeriodicalIF":16.6,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143413877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How bad is your cough? The McMaster Cough Severity Questionnaire as a new tool to measure chronic cough. 你的咳嗽有多严重?麦克马斯特咳嗽严重程度问卷作为慢性咳嗽测量的新工具。
IF 16.6 1区 医学
European Respiratory Journal Pub Date : 2025-02-06 Print Date: 2025-02-01 DOI: 10.1183/13993003.02289-2024
Richard D Turner, Surinder S Birring
{"title":"How bad is your cough? The McMaster Cough Severity Questionnaire as a new tool to measure chronic cough.","authors":"Richard D Turner, Surinder S Birring","doi":"10.1183/13993003.02289-2024","DOIUrl":"https://doi.org/10.1183/13993003.02289-2024","url":null,"abstract":"","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":"65 2","pages":""},"PeriodicalIF":16.6,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparison of respiratory event-related electroencephalographic activity in obstructive sleep apnoea alone versus co-morbid insomnia and sleep apnoea. 阻塞性睡眠呼吸暂停单独与合并症失眠和睡眠呼吸暂停(COMISA)呼吸事件相关脑电图活动的比较
IF 16.6 1区 医学
European Respiratory Journal Pub Date : 2025-02-06 Print Date: 2025-02-01 DOI: 10.1183/13993003.02087-2024
Ali Abdul Ghafoor, Joshua B Hicks, A J Hirsch Allen, Andrew E Beaudin, Fredric Series, Amrit Singh, Patrick J Hanly, Ali Azarbarzin, Najib T Ayas, Mohammadreza Hajipour
{"title":"A comparison of respiratory event-related electroencephalographic activity in obstructive sleep apnoea alone <i>versus</i> co-morbid insomnia and sleep apnoea.","authors":"Ali Abdul Ghafoor, Joshua B Hicks, A J Hirsch Allen, Andrew E Beaudin, Fredric Series, Amrit Singh, Patrick J Hanly, Ali Azarbarzin, Najib T Ayas, Mohammadreza Hajipour","doi":"10.1183/13993003.02087-2024","DOIUrl":"10.1183/13993003.02087-2024","url":null,"abstract":"","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":" ","pages":""},"PeriodicalIF":16.6,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142947046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tracing the origins of fibrotic fibroblasts: does the name matter? Look at the genes! 追踪纤维化成纤维细胞的起源:名称重要吗?看看这些基因!
IF 16.6 1区 医学
European Respiratory Journal Pub Date : 2025-02-06 Print Date: 2025-02-01 DOI: 10.1183/13993003.02170-2024
Arnaud A Mailleux, Aurélien Justet
{"title":"Tracing the origins of fibrotic fibroblasts: does the name matter? Look at the genes!","authors":"Arnaud A Mailleux, Aurélien Justet","doi":"10.1183/13993003.02170-2024","DOIUrl":"https://doi.org/10.1183/13993003.02170-2024","url":null,"abstract":"","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":"65 2","pages":""},"PeriodicalIF":16.6,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
GOLD Science Committee recommendations for the use of pre- and post-bronchodilator spirometry for the diagnosis of COPD. GOLD科学委员会关于使用支气管扩张剂前后肺活量测定法诊断COPD的建议。
IF 16.6 1区 医学
European Respiratory Journal Pub Date : 2025-02-06 Print Date: 2025-02-01 DOI: 10.1183/13993003.01603-2024
Dave Singh, Robert Stockley, Antonio Anzueto, Alvar Agusti, Jean Bourbeau, Bartolome R Celli, Gerard J Criner, MeiLan K Han, Fernando J Martinez, Maria Montes de Oca, Obianuju B Ozoh, Alberto Papi, Ian Pavord, Nicolas Roche, Sandeep Salvi, Don D Sin, Thierry Troosters, Jadwiga Wedzicha, Jinping Zheng, Claus Volgelmeier, David Halpin
{"title":"GOLD Science Committee recommendations for the use of pre- and post-bronchodilator spirometry for the diagnosis of COPD.","authors":"Dave Singh, Robert Stockley, Antonio Anzueto, Alvar Agusti, Jean Bourbeau, Bartolome R Celli, Gerard J Criner, MeiLan K Han, Fernando J Martinez, Maria Montes de Oca, Obianuju B Ozoh, Alberto Papi, Ian Pavord, Nicolas Roche, Sandeep Salvi, Don D Sin, Thierry Troosters, Jadwiga Wedzicha, Jinping Zheng, Claus Volgelmeier, David Halpin","doi":"10.1183/13993003.01603-2024","DOIUrl":"10.1183/13993003.01603-2024","url":null,"abstract":"<p><p>The Global Initiative for Chronic Obstructive Lung Disease (GOLD) report states that the diagnosis of COPD should be considered in individuals with chronic respiratory symptoms and/or exposure to risk factors. Forced spirometry demonstrating airflow obstruction after bronchodilation is required to confirm the diagnosis using a threshold of forced expiratory volume in 1 s (FEV<sub>1</sub>)/forced vital capacity (FVC) ratio <0.7. This GOLD Science Committee review weighs the evidence for using pre- or post-bronchodilator (BD) spirometry to diagnose COPD. Cohort studies have shown that pre- and post-BD spirometry give concordant diagnostic results in most cases, although the prevalence of COPD is up to 36% lower with post-BD values. Discordant results may occur in \"volume\" or \"flow\" responders. Volume responders have reduced FVC due to gas trapping causing FEV<sub>1</sub>/FVC ≥0.7 pre-BD, but a volume response occurs post-BD with a greater improvement in FVC relative to FEV<sub>1</sub> decreasing the ratio to <0.7. Flow responders show a greater FEV<sub>1</sub> improvement relative to FVC which may increase FEV<sub>1</sub>/FVC from <0.7 pre-BD to ≥0.7 post-BD; these individuals have an increased likelihood of developing post-BD obstruction during follow-up and require monitoring longitudinally. GOLD 2025 recommends using pre-BD spirometry to rule out COPD and post-BD measurements to confirm the diagnosis. This will reduce clinical workload. Post-BD results close to the threshold should be repeated to ensure a correct diagnosis is made. Post-BD measurements ensure that volume responders are not overlooked and limit COPD overdiagnosis.</p>","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":" ","pages":""},"PeriodicalIF":16.6,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11799884/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142784618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular risk assessment in patients with COPD: reduce, reuse and recycle. COPD患者心血管风险评估:减少、再利用和再循环。
IF 16.6 1区 医学
European Respiratory Journal Pub Date : 2025-02-06 Print Date: 2025-02-01 DOI: 10.1183/13993003.02103-2024
Miguel Divo, Ciro Casanova, Victor Pinto-Plata
{"title":"Cardiovascular risk assessment in patients with COPD: reduce, reuse and recycle.","authors":"Miguel Divo, Ciro Casanova, Victor Pinto-Plata","doi":"10.1183/13993003.02103-2024","DOIUrl":"https://doi.org/10.1183/13993003.02103-2024","url":null,"abstract":"","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":"65 2","pages":""},"PeriodicalIF":16.6,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply: A recommendation for increased airflow to relieve breathlessness: evidence in context is a strength of the GRADE approach. 回复:建议增加气流以缓解呼吸困难:上下文证据是GRADE方法的优势。
IF 16.6 1区 医学
European Respiratory Journal Pub Date : 2025-02-06 Print Date: 2025-02-01 DOI: 10.1183/13993003.02463-2024
Anne E Holland, Claudia Bausewein, Natasha Smallwood, Magnus Ekström
{"title":"Reply: A recommendation for increased airflow to relieve breathlessness: evidence in context is a strength of the GRADE approach.","authors":"Anne E Holland, Claudia Bausewein, Natasha Smallwood, Magnus Ekström","doi":"10.1183/13993003.02463-2024","DOIUrl":"https://doi.org/10.1183/13993003.02463-2024","url":null,"abstract":"","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":"65 2","pages":""},"PeriodicalIF":16.6,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extracorporeal photopheresis for the prevention of rejection after lung transplantation: a prospective randomised controlled trial. 体外光疗预防肺移植后排斥反应的前瞻性随机对照试验。
IF 16.6 1区 医学
European Respiratory Journal Pub Date : 2025-02-06 Print Date: 2025-02-01 DOI: 10.1183/13993003.00733-2024
Alberto Benazzo, Ara Cho, Sophia Auner, Stefan Schwarz, Zsofia Kovacs, Dariga Ramazanova, Vera Kolovratova, Manuela Branka, Gabriela Muraközy, Elisabeth Hielle-Wittmann, Clemens Aigner, Konrad Hoetzenecker, Thomas Wekerle, Nina Worel, Robert Knobler, Peter Jaksch
{"title":"Extracorporeal photopheresis for the prevention of rejection after lung transplantation: a prospective randomised controlled trial.","authors":"Alberto Benazzo, Ara Cho, Sophia Auner, Stefan Schwarz, Zsofia Kovacs, Dariga Ramazanova, Vera Kolovratova, Manuela Branka, Gabriela Muraközy, Elisabeth Hielle-Wittmann, Clemens Aigner, Konrad Hoetzenecker, Thomas Wekerle, Nina Worel, Robert Knobler, Peter Jaksch","doi":"10.1183/13993003.00733-2024","DOIUrl":"10.1183/13993003.00733-2024","url":null,"abstract":"<p><strong>Background: </strong>Lung transplant recipients have the worst long-term outcomes of all solid organs due to acute rejection and chronic lung allograft dysfunction (CLAD). Our objective was to investigate the efficacy of extracorporeal photopheresis (ECP) as a prophylactic treatment to prevent acute cellular rejection (ACR), cytomegalovirus (CMV) infections and reduce the risk of CLAD.</p><p><strong>Methods: </strong>This was a single-centre prospective randomised controlled trial conducted at the Medical University of Vienna (Vienna, Austria) between 2018 and 2020. It included 31 COPD recipients per group. The treatment group underwent ECP in addition to a standard triple-drug immunosuppression protocol after lung transplantation. The control group received standard triple-drug immunosuppressive therapy. The primary outcome was a composite outcome defined as incidence of high-grade ACR, CMV infection or CLAD within 24 months after lung transplantation.</p><p><strong>Results: </strong>In the control group, 19 patients (61.3%) achieved the primary combined end-point compared with only six patients (19.4%) in the treatment group (p<0.001). Freedom from high-grade ACR was significantly greater in the ECP group (p=0.045). Cumulative A scores were significantly lower in the ECP group than in the control group at 3 months (0.18±0.44 <i>versus</i> 0.56±0.94; p<0.05) and at 12 months (0.25±0.48 <i>versus</i> 1.0±1.45; p=0.002). The rate of infections was lower in the ECP group with five cases and 67 cumulative hospital days compared with 22 cases and 309 days in the control group (p=0.002). Freedom from CLAD at 3 years was significantly greater in the ECP group (p=0.015).</p><p><strong>Conclusion: </strong>Adding ECP to standard triple immunosuppression resulted in a significant reduction of the number of ACR episodes and significantly lower incidence of CLAD.</p>","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":" ","pages":""},"PeriodicalIF":16.6,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11799887/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142784405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信